Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Diseases × Mammaplasty × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Postoperative Complications 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Ductal 1 Breast Diseases 1 Breast Carcinoma In Situ 1 Breast Cancer Female 1

Interventions

Docetaxel 6 palbociclib 5 exemestane 5 Trastuzumab 5 Letrozole 5 Anastrozole 5 entinostat 4 Fulvestrant 4 Cyclophosphamide 4 ribociclib 3 pyrotinib 3 Doxorubicin 3 abemaciclib 2 Sodium Chloride 2 Paclitaxel 2 Lapatinib 2 Gonadotropin-Releasing Hormone 2 Exercise 2 Everolimus 2 Epirubicin 2 Capecitabine 2 Botulinum Toxins, Type A 2 AZD9833 2 sacubitril and valsartan sodium hydrate drug combination 1 pertuzumab 1 pembrolizumab 1 pegfilgrastim 1 ipatasertib 1 gadoterate meglumine 1 figitumumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02557906 2018-03-13

POBRAD-M

King's College London

Phase NA Unknown

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡